Correction: Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476455/
https://www.ncbi.nlm.nih.gov/pubmed/32895295
http://dx.doi.org/10.1136/jitc-2020-001089corr1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476455/
https://www.ncbi.nlm.nih.gov/pubmed/32895295
http://dx.doi.org/10.1136/jitc-2020-001089corr1

Ejemplares similares